Simple jQuery Dropdowns

Browsing by Author Hopital Beaujon

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
13-Nov-2019Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss; Jean Ralph Zahar; Jeff Alder; Karim Asehnoune; Matteo Bassetti; Marc J.M. Bonten; Jean Chastre; Jan De Waele; George Dimopoulos; Philippe Eggimann; Marc Engelhardt; Santiago Ewig; Marin Kollef; Jeffrey Lipman; Carlos Luna; Ignacio Martin-Loeches; Leonardo Pagani; Lucy B. Palmer; Laurent Papazian; Garyphallia Poulakou; Philippe Prokocimer; Jordi Rello; John H. Rex; Andrew F. Shorr; George H. Talbot; Visanu Thamlikitkul; Antoni Torres; Richard G. Wunderink; Jean François Timsit; F2G Limited; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias; Regional Hospital of Bolzano; Augusta Krankenanstalt; University Hospital of Ghent; University of Athens Medical School; University Medical Center Utrecht; Royal Brisbane and Women's Hospital; Washington Hospital Center; Sotiria General Hospital; Stony Brook University; Università degli Studi di Udine; Basilea Pharmaceutica Ltd.; Hôtel Dieu CHU de Nantes; Centre Hospitalier Universitaire Vaudois; Hôpital Bichat-Claude-Bernard AP-HP; Washington University School of Medicine in St. Louis; University of Witwatersrand; Hôpital Universitaire Pitié Salpêtrière; Attikon University Hospital; Northwestern University Feinberg School of Medicine; Hôpital Nord AP-HM; Faculty of Medicine, Siriraj Hospital, Mahidol University; Trinity College Dublin; Universite Paris 13; Hospital de Clinicas Jose de San Martin; Hopital Avicenne; Merck & Co., Inc.; Hopital Beaujon; Universite Paris 7- Denis Diderot; Universitat de Barcelona; Inserm; Bayer US LLC; Talbot Advisors LLC
1-Nov-2011Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or CY. F. Liaw; J. D. Jia; H. L.Y. Chan; K. H. Han; T. Tanwandee; W. L. Chuang; D. M. Tan; X. Y. Chen; E. Gane; T. Piratvisuth; L. Chen; Q. Xie; J. J.Y. Sung; C. Wat; C. Bernaards; Y. Cui; P. Marcellin; Chang Gung University College of Medicine; Capital Medical University China; Chinese University of Hong Kong; Yonsei University College of Medicine; Mahidol University; Kaohsiung Medical University Chung-Ho Memorial Hospital; Xiangya Hospital of Central-south University; Auckland City Hospital; Prince of Songkla University; Fudan University; Ruijin Hospital; Roche Products Limited UK; Genentech Incorporated; Shanghai Roche Pharmaceuticals Ltd; Hopital Beaujon